Evaluation of Sex Differences in the Efficacy and Safety of Tofacitinib in Patients with Active Psoriatic Arthritis: A Post Hoc Analysis of Two Phase 3 Randomized Controlled Trials

被引：0
|
作者：
Eder, Lihi [1 ,2 ]
Gladman, Dafna [3 ]
Aydin, Sibel [4 ]
Ogdie, Alexis [5 ]
Shi, Harry [6 ]
Landry, Pierre-Alexandre [7 ]
Luna, Rayana [7 ]
机构：
[1] Womens Coll Res Inst, Toronto, ON, Canada
[2] Univ Toronto, Toronto, ON, Canada
[3] Univ Toronto, Krembil Res Inst, Dept Med, Toronto Western Hosp, Toronto, ON, Canada
[4] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada
[5] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
[6] Pfizer Inc, Collegeville, PA USA
[7] Pfizer Canada ULC, Kirkland, WA USA
来源：
JOURNAL OF RHEUMATOLOGY | 2020年 / 47卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
10
引用
收藏
页码：1043 / 1044
页数：2
相关论文
共 50 条
  • [1] Evaluation of Sex Differences in the Efficacy and Safety of Tofacitinib in Patients with Active Psoriatic Arthritis: A Post Hoc Analysis of Two Phase 3 Randomized Controlled Trials
    Eder, Lihi
    Gladman, Dafna
    Aydin, Sibel Zehra
    Ogdie, Alexis
    Shi, Harry
    Landry, Pierre-Alexandre
    Luna, Rayana
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [2] Sex differences in the efficacy, safety and persistence of patients with psoriatic arthritis treated with tofacitinib: a post-hoc analysis of phase 3 trials and long-term extension
    Eder, Lihi
    Gladman, Dafna D.
    Mease, Philip
    Pollock, Remy A.
    Luna, Rayana
    Aydin, Sibel Z.
    Ogdie, Alexis
    Polachek, Ari
    Gruben, David
    Cadatal, Mary Jane
    Kinch, Cassandra
    Strand, Vibeke
    [J]. RMD OPEN, 2023, 9 (01):
  • [3] SEX DIFFERENCES IN THE EFFICACY AND SAFETY OF TOFACITINIB IN RHEUMATOID ARTHRITIS PATIENTS: A POST HOC ANALYSIS OF PHASE 3 AND LONG-TERM EXTENSION TRIALS
    Jones, H. N.
    Strand, V.
    Schulze-Koops, H.
    Mysler, E.
    Kinch, C.
    Gruben, D. C.
    Germino, R.
    Connell, C. A.
    Eder, L.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 565 - 566
  • [4] Sex Differences in the Efficacy and Safety of Tofacitinib in Rheumatoid Arthritis Patients: A Post Hoc Analysis of Phase 3 and Long-Term Extension Trials
    Jones, Niall
    Strand, Vibeke
    Schulze-Koops, Hendrik
    Mysler, Eduardo
    Kinch, Cassandra D.
    Gruben, David
    Germino, Rebecca
    Connell, Carol A.
    Eder, Lihi
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [5] Sex Differences in the Efficacy and Safety of Tofacitinib in Patients With Rheumatoid Arthritis: A Post Hoc Analysis of Phase 3 and Long-Term Extension Trials
    Jones, Niall
    Strand, Vibeke
    Schulze-Koops, Hendrik
    Mysler, Eduardo
    Kinch, Cassandra
    Gruben, David
    Germino, Rebecca
    Connell, Carol
    Eder, Lihi
    [J]. JOURNAL OF RHEUMATOLOGY, 2021, 48 (07) : 1145 - 1145
  • [6] Efficacy and safety of tofacitinib by background methotrexate dose in psoriatic arthritis: post hoc exploratory analysis from two phase III trials
    Kivitz, Alan J.
    FitzGerald, Oliver
    Nash, Peter
    Pang, Shirley
    Azevedo, Valderilio F.
    Wang, Cunshan
    Takiya, Liza
    [J]. CLINICAL RHEUMATOLOGY, 2022, 41 (02) : 499 - 511
  • [7] Efficacy and safety of tofacitinib by background methotrexate dose in psoriatic arthritis: post hoc exploratory analysis from two phase III trials
    Alan J. Kivitz
    Oliver FitzGerald
    Peter Nash
    Shirley Pang
    Valderilio F. Azevedo
    Cunshan Wang
    Liza Takiya
    [J]. Clinical Rheumatology, 2022, 41 : 499 - 511
  • [8] TOFACITINIB TREATMENT IN PATIENTS WITH PSORIATIC ARTHRITIS AND PROBABLE DEPRESSION AND/OR ANXIETY: A POST HOC ANALYSIS OF TWO PHASE 3 CLINICAL TRIALS
    Gossec, L.
    Citera, G.
    Sellas-Fernandez, A.
    Gruben, D. C.
    Valderrama, M.
    Gomez, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 782 - 782
  • [9] COMPARISON OF THE EFFICACY AND SAFETY OF TOFACITINIB AND APREMILAST IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: A BAYESIAN NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Lee, Young Ho
    Song, Gwan Gyu
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1275 - 1276
  • [10] Comparison of the Efficacy and Safety of Tofacitinib and Apremilast in Patients with Active Psoriatic Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
    Gwan Gyu Song
    Young Ho Lee
    [J]. Clinical Drug Investigation, 2019, 39 : 421 - 428
12345